Case Type: Drug

Ozempic, Wegovy, and Mounjaro Lawyer In 2017, Novo Nordisk introduced Ozempic to the market as a medication designed for the treatment of type 2 diabetes. However, healthcare professionals soon observed an intriguing side effect among some individuals who used this drug: appetite suppression leading to subsequent weight loss. This unexpected yet beneficial outcome sparked significant […]